ETF MANAGERS GROUP LLC 13D and 13G filings for Zynerba Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-14 3:52 pm Sale | 2022-02-11 | 13G | Zynerba Pharmaceuticals, Inc. ZYNE | ETF MANAGERS GROUP LLC | 3,526,304 8.560% | -1,087,028 (-23.56%) | Filing |
| 2021-06-01 2:00 pm Purchase | 2021-05-28 | 13G | Zynerba Pharmaceuticals, Inc. ZYNE | ETF MANAGERS GROUP LLC | 4,613,332 11.180% | 2,404,548 (+108.86%) | Filing |
| 2021-05-11 1:13 pm Purchase | 2021-05-10 | 13G | Zynerba Pharmaceuticals, Inc. ZYNE | ETF MANAGERS GROUP LLC | 2,208,784 5.350% | 298,590 (+15.63%) | Filing |
| 2021-03-11 11:12 am Sale | 2021-03-09 | 13G | Zynerba Pharmaceuticals, Inc. ZYNE | ETF MANAGERS GROUP LLC | 1,910,194 4.630% | -90,394 (-4.52%) | Filing |
| 2021-01-08 1:04 pm Purchase | 2021-01-07 | 13G | Zynerba Pharmaceuticals, Inc. ZYNE | ETF MANAGERS GROUP LLC | 2,000,588 6.800% | 421,427 (+26.69%) | Filing |
| 2020-11-16 12:05 pm Purchase | 2020-11-13 | 13G | Zynerba Pharmaceuticals, Inc. ZYNE | ETF MANAGERS GROUP LLC | 1,579,161 5.360% | 371,035 (+30.71%) | Filing |
| 2020-05-11 2:43 pm Sale | 2020-05-08 | 13G | Zynerba Pharmaceuticals, Inc. ZYNE | ETF MANAGERS GROUP LLC | 1,208,126 4.840% | -1,475,277 (-54.98%) | Filing |